Home
Conditions
Anticoagulants and Bleeding Disorders

Clinical trial condition

Anticoagulants and Bleeding Disorders

Explore clinical trials studying Anticoagulants and Bleeding Disorders. Study availability and eligibility vary by location and protocol.

21 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Anticoagulants and Bleeding Disorders trial results

Completed

Bleeding Oral Anticoagulant Analyzer (BOA)

NCT05026281

Conditions: Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Disease Attributes, +9 more
Locations: University Hospital Clermont-Ferrand, France

Grenoble University Hospital Grenoble, France

Edouard Herriot University Hospital Lyon, France

La Pitié-Salpétrière Paris, France

View Trial Details

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

NCT05224388

Conditions: Anticoagulants and Bleeding Disorders, COVID-19, Cardiovascular Diseases, +24 more
Locations: Ghent University Hospital Ghent, Belgium

View Trial Details

Completed

Nadroparin Pharmacokinetics in Different Stages of COVID-19

NCT05621915

Conditions: Anticoagulants and Bleeding Disorders, COVID-19, Cardiovascular Diseases, +20 more
Locations: 2nd Department of Anesthesiology and Critical Care, Medical University of Lublin Lublin, Lublin Voivodeship, Poland

View Trial Details

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666

Conditions: Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +7 more
Locations: Kaiser Permanente Northern California Oakland, California, United States

Kaiser Permanente Southern California Pasadena, California, United States

View Trial Details

Completed

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic

NCT04444700

Conditions: Anticoagulants and Bleeding Disorders, COVID, Cardiovascular Diseases, +19 more
Locations: Hospital das Clínicas da FMUSP São Paulo, Brazil

View Trial Details

Completed

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic

NCT03112525

Conditions: Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Hematologic Diseases, +4 more
Locations: HUG Geneva, Switzerland

View Trial Details

Completed

Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus

NCT03232398

Conditions: Acute Myocardial Infarction, Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, +6 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Completed

Oral Surgery in Patients Taking Direct Oral Anticoagulants

NCT04505475

Conditions: Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Dentoalveolar Haemorrhage, +11 more
Locations: Dental Clinic of Vojvodina Novi Sad, Vojvodina, Serbia

View Trial Details

Completed

Anticoagulation and Antiplatelet Management During Perioperative Period

NCT03871283

Conditions: Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Hematologic Diseases, +4 more
Locations: ERASME Hospital Brussels, Belgium

View Trial Details

Completed

Safety and Efficacy of Edoxaban in Thoracoscopic Ablation

NCT04121767

Conditions: Anticoagulants and Bleeding Disorders, Arrhythmias, Cardiac, Atrial Fibrillation, +9 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Anticoagulants and Bleeding Disorders

Anticoagulants and Bleeding Disorders trial results

Related conditions